Gyrodyne
GYRO
11 hedge funds and large institutions have $8.6M invested in Gyrodyne in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 4 increasing their positions, 0 reducing their positions, and closing their positions.
2.39% more ownership
Funds ownership: 32.51% → 34.9% (+2.4%)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$597K |
| 2 |
Gabelli & Co Investment Advisers
Rye,
New York
|
+$3.41K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.9K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$955 |
Top Sellers
GYRO Hedge Fund Activity: Q3 2020 in Review
11 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Gyrodyne (GYRO) for Q3 2020, worth a combined $8.6M — up 9.6% from $7.85M a quarter earlier.
Fund positioning in GYRO was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), adding an estimated $597K.
- 11 institutional investors held Gyrodyne (GYRO) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $8.6M of Gyrodyne stock for Q3 2020, up 9.6% quarter-over-quarter.
- 0 funds opened new Gyrodyne positions in Q3 2020 and 0 closed out.
- The largest Gyrodyne buyer in Q3 2020 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $597K added.
Based on aggregated 13F filings for Q3 2020.